EUVIMEDEUVIMED entdecken
Open Access

Interleukin-2 is a potent latency reversal agent in people with treated HIV-1

Michael L Freeman iD, Brian M Clagett iD, Konstantin Leskov iD, Daniela Moisi, George A Yendewa, Scott F Sieg iD, Gregory M Laird iD, Jonathan Karn iD, Jeffrey M Jacobson iD, Benigno Rodriguez, Michael M Lederman iD

Science Advances · 2025

DOI: 10.1126/sciadv.aea4268 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Michael L Freeman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Interleukin-2, HIV-1, HIV Infections, Virus Latency. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Gilead Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eliciting HIV-1 expression from latently infected CD4 + T cells allows these rare reservoir cells to become targets of the immune system and may also result in death of reservoir cells via virus-induced cytopathy. We asked whether administration of recombinant interleukin-2 (rIL-2) to people with HIV-1 (PWH) on antiretroviral therapy (ART) would induce HIV-1 replication and activate cellular immunity. Nine men with ART-suppressed HIV-1 completed a single 4-day cycle of rIL-2 administration. Plasma HIV-1 RNA levels rose from

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-2HIV-1HIV InfectionsVirus LatencyAnti-HIV AgentsHumansMaleCD4-Positive T-LymphocytesAdultMiddle AgedViral LoadRNA, ViralLymphocyte ActivationVirus ReplicationRecombinant ProteinsKiller Cells, Natural

Substanzen

Interleukin-2RNA, ViralAnti-HIV AgentsRecombinant Proteins

Autor:innen und Institutionen

  • Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.
  • Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
  • Center for Global Health and Diseases, Department of Pathology, Case Western Reserve University, Cleveland, OH, USA.
  • Department of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, OH, USA.
  • Accelevir Diagnostics, Baltimore, MD, USA.

ORCID-Profile: Michael L Freeman, Brian M Clagett, Konstantin Leskov, Scott F Sieg, Gregory M Laird, Jonathan Karn, Jeffrey M Jacobson, Michael M Lederman

Förderung

  • Gilead Sciences

Zitieren

APA

Freeman, M. L., Clagett, B. M., Leskov, K., Moisi, D., Yendewa, G. A., Sieg, S. F., Laird, G. M., Karn, J., Jacobson, J. M., Rodriguez, B., & Lederman, M. M. (2025). Interleukin-2 is a potent latency reversal agent in people with treated HIV-1. Science Advances. https://doi.org/10.1126/sciadv.aea4268

Vancouver

Freeman ML, Clagett BM, Leskov K, Moisi D, Yendewa GA, Sieg SF, et al. Interleukin-2 is a potent latency reversal agent in people with treated HIV-1. Science Advances. 2025. doi:10.1126/sciadv.aea4268

BibTeX
@article{Freeman2025,
  author = {Freeman, Michael L and Clagett, Brian M and Leskov, Konstantin and Moisi, Daniela and Yendewa, George A and Sieg, Scott F and Laird, Gregory M and Karn, Jonathan and Jacobson, Jeffrey M and Rodriguez, Benigno and Lederman, Michael M},
  title = {Interleukin-2 is a potent latency reversal agent in people with treated HIV-1},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.aea4268}
}
Kostenlos starten →